Submission Details
| 510(k) Number | K252956 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 16, 2025 |
| Decision Date | December 18, 2025 |
| Days to Decision | 93 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K252956 is an FDA 510(k) clearance for the Helo Thrombectomy System, a Peripheral Mechanical Thrombectomy With Aspiration (Class II — Special Controls, product code QEW), submitted by Endovascular Engineering, Inc. (Menlo Park, US). The FDA issued a Cleared decision on December 18, 2025, 93 days after receiving the submission on September 16, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.5150.
| 510(k) Number | K252956 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 16, 2025 |
| Decision Date | December 18, 2025 |
| Days to Decision | 93 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | QEW — Peripheral Mechanical Thrombectomy With Aspiration |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.5150 |
| Definition | To Mechanically Disrupt Thrombus And/or Debris Prior To Removal From The Peripheral Vasculature Through Aspiration. |